ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
May 05 2008 - 6:00AM
PR Newswire (US)
Conference call scheduled for May 12, 2008 at 1:30 p.m. (Pacific);
simultaneous webcast at http://www.adventrx.com SAN DIEGO, May 5
/PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX)
today announced that it will host a conference call with
simultaneous webcast to discuss first quarter 2008 results on
Monday, May 12th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern.
Evan M. Levine, Chief Executive Officer and President, and Mark N.
K. Bagnall, Chief Financial Officer and Executive Vice President,
will host the conference call. The conference call may be accessed
by dialing (888) 215-7013 for domestic callers and (913) 312-1235
for international callers. The webcast will be available live via
the Internet by accessing ADVENTRX's web site at
http://www.adventrx.com/ under "Investors". Replays of the webcast
will be available for 30 days on ADVENTRX's web site, and a phone
replay will be available through May 17, 2008 by dialing (888)
203-1112 and entering the passcode 5439297. About ADVENTRX
Pharmaceuticals ADVENTRX Pharmaceuticals is a biopharmaceutical
company focused on in- licensing, developing and commercializing
proprietary product candidates primarily for the treatment of
cancer and infectious disease. The Company seeks to improve the
performance and commercial potential of existing treatments by
addressing problems associated with these treatment regimens. More
information can be found on ADVENTRX's web site at
http://www.adventrx.com/. DATASOURCE: ADVENTRX Pharmaceuticals,
Inc. CONTACT: Ioana C. Hone of ADVENTRX Pharmaceuticals, Inc.,
+1-858-552-0866 Web site: http://www.adventrx.com/
Copyright
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jul 2023 to Jul 2024